Annual EBIT
-$51.98 M
-$14.25 M-37.76%
December 1, 2023
Summary
- As of February 22, 2025, BCAX annual earnings before interest & taxes is -$51.98 million, with the most recent change of -$14.25 million (-37.76%) on December 1, 2023.
- During the last 3 years, BCAX annual EBIT has fallen by -$14.25 million (-37.76%).
- BCAX annual EBIT is now -37.76% below its all-time high of -$37.73 million, reached on December 1, 2022.
Performance
BCAX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.63 M
NaN%
September 30, 2024
Summary
- As of February 22, 2025, BCAX quarterly earnings before interest & taxes is -$20.63 million
- Over the past year, BCAX quarterly EBIT has dropped by -$11.10 million (-116.45%).
- BCAX quarterly EBIT is now -116.45% below its all-time high of -$9.53 million, reached on September 30, 2023.
Performance
BCAX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$20.63 M
NaN%
September 30, 2024
Summary
- As of February 22, 2025, BCAX TTM earnings before interest & taxes is -$20.63 million
- Over the past year, BCAX TTM EBIT has dropped by -$11.10 million (-116.45%).
- BCAX TTM EBIT is now -116.45% below its all-time high of -$9.53 million, reached on September 30, 2023.
Performance
BCAX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCAX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.8% | -116.5% | -116.5% |
| 3 y3 years | -37.8% | -116.5% | -116.5% |
| 5 y5 years | -37.8% | -116.5% | -116.5% |
BCAX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.8% | at low | -116.5% | at low | -116.5% | at low |
| 5 y | 5-year | -37.8% | at low | -116.5% | at low | -116.5% | at low |
| alltime | all time | -37.8% | at low | -116.5% | at low | -116.5% | at low |
Bicara Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.63 M(+116.5%) | -$20.63 M(+116.5%) |
| Dec 2023 | -$51.98 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.53 M | -$9.53 M |
| Dec 2022 | -$37.73 M | - | - |
FAQ
- What is Bicara Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bicara Therapeutics?
- What is Bicara Therapeutics annual EBIT year-on-year change?
- What is Bicara Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly EBIT year-on-year change?
- What is Bicara Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bicara Therapeutics?
- What is Bicara Therapeutics TTM EBIT year-on-year change?
What is Bicara Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BCAX is -$51.98 M
What is the all time high annual EBIT for Bicara Therapeutics?
Bicara Therapeutics all-time high annual earnings before interest & taxes is -$37.73 M
What is Bicara Therapeutics annual EBIT year-on-year change?
Over the past year, BCAX annual earnings before interest & taxes has changed by -$14.25 M (-37.76%)
What is Bicara Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BCAX is -$20.63 M
What is the all time high quarterly EBIT for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly earnings before interest & taxes is -$9.53 M
What is Bicara Therapeutics quarterly EBIT year-on-year change?
Over the past year, BCAX quarterly earnings before interest & taxes has changed by -$11.10 M (-116.45%)
What is Bicara Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BCAX is -$20.63 M
What is the all time high TTM EBIT for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM earnings before interest & taxes is -$9.53 M
What is Bicara Therapeutics TTM EBIT year-on-year change?
Over the past year, BCAX TTM earnings before interest & taxes has changed by -$11.10 M (-116.45%)